Skip to main content

Advertisement

Table 1 Clinical and biological characteristics of AML patients

From: Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells

Patients Age Sex Previous malignant disease FAB Membrane molecules Karyotype FLT3 LM FLT3 Asp835 Survival (Weeks)
      CD 13 CD 14 CD 15 CD 33 CD 34     
# 1 72 M Residive AML M1 + - + + - Normal wt wt 6
# 2 34 F - AML M5a - - + + - 46 XX, t(9;11), (q22;q23) wt 0.31 >24 (Tx)
# 3 55 M - Atypical + - + + - Multiple wt wt >23
  1. The patients were randomly selected; their clinical and biological data are included as background information.